The exact mechanisms of interfering with glucose homeostasis are still unclear, but experimental studies on β-cells showed that the monoclonal antibody that blocks the RANK/RANKL pathway might protect the pancreatic cell against dysfunction and apoptosis induced by diabetes-induced inflammatory cytokines and reactive oxygen species [130]. Here, TNFRSF11A is linked to diabetes mellitus.